Lexeo Therapeutics, Inc. (LXEO)

4.07 -0.13 (-3.10%) USD  |  NASDAQ  |  Sep 21, 16:00
4.07 0.00 (0.00%) After-Hours: 20:00
More

Lexeo Therapeutics EPS Diluted (Quarterly) : -0.3021 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for LXEO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -0.3021
March 31, 2026 -0.2488
December 31, 2025 -0.274
September 30, 2025 -0.3326
June 30, 2025 -0.5991
March 31, 2025 -0.9862
December 31, 2024 -0.7838
September 30, 2024 -0.8919
June 30, 2024 -0.6435
Date Value
March 31, 2024 -0.7749
December 31, 2023 -0.5325
September 30, 2023 -0.7546
June 30, 2023 -0.5044
March 31, 2023 -0.7002
December 31, 2022 -0.547
September 30, 2022 -0.64
June 30, 2022 -0.5683
March 31, 2022 -0.4692

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. -1.355
Oncolytics Biotech, Inc. -0.0788
Sangamo Therapeutics, Inc. -0.0796
Sarepta Therapeutics, Inc. -0.0464
Anixa Biosciences, Inc. -0.0762

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -25.87M
Total Expenses (Quarterly) 25.87M
Enterprise Value 125.32M
Earnings Yield -28.44%
Normalized Earnings Yield -28.44